Stephanie Link Sells Eli Lilly, Buys Intuitive Surgical on Stronger Quarter

Portfolio Adjustments

• 🎯 Stephanie Link sold her position in Eli Lilly primarily because she prefers Intuitive Surgical due to its stronger recent quarter.
• 💡 Intuitive Surgical demonstrated improved procedure volumes, derisked gross margins, and reduced operating expenses.
• 🚀 Link sees a significant total addressable market for Intuitive Surgical's offerings.

Eli Lilly Valuation and Outlook

• 💰 While Link made a profit on Eli Lilly, she found it to be expensive at its current valuation.
• ⚠️ She indicated a potential interest in buying back into Eli Lilly if the stock pulls back to a more reasonable valuation.
• 🚫 The sale of Eli Lilly was unrelated to the news regarding drug pricing executive orders.

Impact of Drug Pricing Executive Order

• 📉 The executive order on drug prices is expected to most significantly affect pharmacy benefit managers (PBMs).
• ⚠️ Companies like CVS, Sign, McKesson, Quest Diagnostics, and UnitedHealth Group saw significant stock price declines.
• 🚫 Conversely, most pharmaceutical names, like Merck, were up, suggesting the market does not see them as directly impacted by the PBM squeeze.

Market Reaction to Drug Pricing

• 📊 The market appears to believe the squeeze will come from the middlemen (PBMs) in the drug supply chain.
• 🗣️ The executive order aims to equalize drug prices by having the US pay what other developed nations pay, a move previously hindered by pharmaceutical lobbying.